This program is designed to enable entrepreneurs and biopharma marketers to engage in an intelligent way to explore beyond-the-pill partnerships.
As we build health solutions, making decisions in office parks and around conference tables, it's easy to lose the individual person through the scale of our work.
SXSW's health track finally got a seat at the big-kids table.
A high-profile cancer track commands attention, while wearables and IBM Watson Health come under fire.
The first days at SXSW Health went deep on entrepreneurship and the marketing thereof.
He instead decided to find a way to make a physician's job easier by creating a clinical messaging platform.
Gilead exec blames PBMs for high drug prices; Google uses AI to detect signs of breast cancer; Sanofi and Regeneron drug effective in treating eczema
The health insurer partnered with Microsoft to use VR and AR technology to gather biometric data.
Microsoft reenters healthcare market; Trump accuses Cummings of avoiding drug-pricing meeting; Trump says ACA replacement plan to be unveiled in March
The Kim Kardashian debacle aside, what makes the platform so potentially valuable to pharma and healthcare marketers is its visual story-telling capability.
Pharmaceutical and healthcare companies use a mix of corporate and brand accounts on Instagram, and some are turning to celebrity influencers.
A bout with Lyme disease led Yee to found a company that helps patients measure and track their breathing patterns.
Merck and Aetna partner in value-based drug pricing; data scientists rising in the biopharma ranks; Japanese pharma leads digital health innovation
Transportation barriers can limit patient involvement in clinical trials.
Novartis forecasts slower growth in 2017; Actelion reports trial failure for PAH drug; HHS nominee Tom Price denies conflict of interest claims
- Five things for pharma marketers to know: Wednesday, March 22, 2017
- Five things for pharma marketers to know: Monday, March 20, 2017
- Novartis aims to bring first oral asthma drug to market in two decades
- Five things for pharma marketers to know: Tuesday, March 21, 2017
- Drugmakers target severe asthma patients with biologics, but payers raise pricing issue
- 2017 Healthcare Marketers Trend Report: All the data in one place
- Infographic: What's next for the point of care market
- Drugmakers again boost DTC spending, to $5.6 billion in 2016
- Publicis Health formalizes new name, promotes 3 execs
- Digital IDs become focus as drugmakers seek to track doctors' behavior online